As of February 2025 Soleno Therapeutics has a market cap of NZ$3.46 Billion. This makes Soleno Therapeutics the world's 4315th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$3.46 B | 1.09% |
2024 | NZ$3.42 B | 76.52% |
2023 | NZ$1.94 B | 7528.64% |
2022 | NZ$25.44 M | -46.92% |
2021 | NZ$47.93 M | -77.49% |
2020 | NZ$0.21 B | 9.24% |
2019 | NZ$0.19 B | 140.82% |
2018 | NZ$80.95 M | 219.34% |
2017 | NZ$25.35 M | 35.61% |
2016 | NZ$18.69 M | -50.66% |
2015 | NZ$37.89 M | 194.04% |
2014 | NZ$12.88 M |